Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market
Everest Medicines (HKEX 1952.HK) announced that it has entered into a commercialization license agreement with ...
📌 Kaynak
Bu özet Antara News (ID) kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →